Precision Diagnostics.
Healthier Outcomes
Providing patients and healthcare professionals with cutting-edge technologies that empower personalized cancer therapy and inform treatment decisions, for a brighter, healthier future.
Learn More
Critical insights for personalized cancer treatment
Canary Onco is transforming cancer care by empowering smarter treatment decisions through advanced genomics. We're ensuring every patient gets their best possible therapy.
Our Test portfolio
We offer a global porfolio of advanced testing services to achieve the ideal for diagnosis
Our precision oncology ecosystem
Empowering you with the knowledge for personalized cancer treatment.
Advancing Care Today
- Patient Support Resources: Providing financial guidance, informed treatment decision support, and valuable educational materials.
- Genomic Testing for Actionable Insights: Offering a comprehensive suite of genomic profiling tests to unlock insights for a wide spectrum of cancer types.
- Personalized Treatment Strategies: Matching patients to targeted therapies, immunotherapies, and appropriate clinical trial options based on their unique genomic profiles.
Transforming Care Tomorrow
- Streamlined Clinical Trial Solutions: Accelerating biopharma research with faster, more efficient clinical trial design, patient support, and screening processes.
- Data-Driven Biomarker Discovery: Leveraging cutting-edge data analysis tools to uncover novel insights that accelerate biomarker research and drug development.
- Accelerated Drug Discovery & Launch: Partnering with the biopharma industry to facilitate the discovery, development, and distribution of the next generation of breakthrough cancer treatments.
Innovating Care Together
- Strategic Partnerships: Collaborating with leading patient advocacy organizations, world-renowned medical centers, and pioneering researchers to revolutionize cancer care.
- Molecular Data Research Initiatives: Empowering researchers to generate new connections and insights that improve patient care.
Why choose us
Working Together for a Future Without Cancer: Canary Onco provides comprehensive solutions
for every stakeholder in the fight against cancer. Select the section that best describes
you
For Patients: Learn about precision treatment and understand genetic
testing.
For Providers: Collaborate with top oncologists and better
serve your patients.
For Biopharma & Research Partners: Partner on CDx
with advanced science.
For Patients
Unlock Your Cancer's Secrets: Genetic Testing for Personalized Treatment
A cancer diagnosis is filled with questions. Gain clarity and confidence in your treatment plan with Canary Onco's genetic testing.
We provide specific genomic insights, revealing the unique molecular makeup of your cancer, so you and your doctor can make informed, personalized choices for your care.
It starts with understanding.
We're here to help you navigate the complexities of cancer treatment and unlock the best path forward.
For Providers
Navigate Cancer Complexity with Confidence: Genetic Testing from Canary Onco
Gain the clarity you need to guide treatment strategies for your advanced cancer patients. Genetic testing helps you determine comprehensive cancer treatment options based on unique cancer features for each patient you treat – and increases their odds for a healthy future. With Canary Onco, unlock the power of precision medicine to guide individualized treatment decisions with confidence.
For Biopharma & Research Partners
Precision Partnering for Breakthrough Therapies: Accelerate Your Oncology Programs with Canary Onco
From initial discovery to launch, Canary Onco provides the global portfolio of tests and services, combined with the expertise of our scientific and regulatory experts, to fit your specific needs. We are your ideal partner to help make your next breakthrough a standard of care.
Trusted by Hospitals Nationwide
Strategic Partnerships
Request a Call Back
Would you like to speak to one of our advisors over the phone? Just submit your details and we’ll be in touch shortly. You can also email us if you would prefer.